How to assess cannabis offers without having conventional metrics

[ad_1]

&#13

(This story is element of MJBizDaily’s premium subscription service, Investor Intelligence.)

Cannabis firms are issuing equity, debt and warrants for acquisitions at a fast pace appropriate now, moves that demand answers to essential queries for keen investors.

  • Do the offers offer management an chance to develop or destroy shareholder worth?
  • Are the offers accretive or dilutive to your ownership stake?

These queries can be complicated to answer when there are scant conventional monetary metric facts such as EBITDA, EPS or cost-free money flow to analyze.

But there are two swift strategies to get your arms about deal economics with just some standard monetary data:

  • Return on capital (ROC).
  • EBITDA per share.

Study additional about how to apply these assessments to cannabis offers at Investor Intelligence.

&#13

[ad_2]

Latest posts